Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 41 of 41 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Advanced Medicine Partners | Activity: Contract Research and Testing | Company Description Advanced Medicine Partners offers process development, manufacturing, analytical development and testing for advanced medicines, specializing in viral vectors for gene and cell therapies. | Location Cary |
| |
Company Asinex | Activity: Contract Research and Testing | Company Description Asinex designs small-molecule libraries and provides lead optimization, custom synthesis and other chemistry services. The Winston-Salem location is the company's U.S. headquarters. | Location Winston-Salem |
| |
Company Asymchem | Activity: Sales and Operations | Company Description Asymchem offers CMC and CDMO services, focused on developing processes for late-phase to commercial APIs and HPAPIs, and small-molecule manufacturing and development. Asymchem is USFDA- and TGA-inspected. | Location Morrisville |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville |
| |
Company Biogen | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. The Drug Substance Campus in RTP is home to biologics production and a patient services contact center. | Location Research Triangle Park |
| |
Company Biogen (Oral Solid Dose Facility) | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. This site houses oral solid dose and anti-sense oligonucleotide production, packaging and fill/finish operations, as well as a Global Business Services center. | Location Research Triangle Park |
| |
Company BridgeBio Gene Therapy | Activity: Research and Development | Company Description BridgeBio Gene Therapy is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Location Raleigh |
| |
Company Brii Biosciences Inc. | Activity: Research and Development | Company Description Brii Biosciences develops therapies focused on infectious diseases and central nervous system diseases where patients experience high levels of unmet medical needs, limited choice and significant social stigmas. | Location Durham |
| |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh |
| |
Company CSL Seqirus | Activity: Production and Manufacturing | Company Description Seqirus manufactures influenza vaccines using both egg-based and cell-based technologies. | Location Holly Springs |
| |
Company Dermavant Sciences | Activity: Research and Development | Company Description Dermavant, a part of the Roivant family of companies, develops therapies for the treatment of skin diseases. | Location Morrisville |
| |
Company Encoded Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Encoded is developing and commercializing gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. | Location Morrisville |
| |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham |
| |
Company Inceptor Bio LLC | Activity: Research and Development | Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. | Location Raleigh |
| |
Company Jaguar Gene Therapy LLC (Analytical Development) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's analytical development lab is located in Durham. | Location Durham |
| |
Company KBI Biopharma Inc. (Corporate HQ) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. | Location Durham |
| |
Company KBI Biopharma Inc. (Patriot Park Facility) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. The Patriot Park Facility is a 150,000 square-foot cGMP biologics manufacturing facility. | Location Durham |
| |
Company KBI Biopharma Inc. (Venture Center Facility) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services. KBI's Venture Center Facility conducts process and analytical development, process characterization and cell line development. | Location Durham |
| |
Company Kowa Research Institute Inc. | Activity: Research and Development | Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. | Location Morrisville |
| |
Company Merck & Co. Inc. (Durham) | Activity: Production and Manufacturing | Company Description Merck manufactures vaccine products at its Durham facility. | Location Durham |
| |
Company Merck & Co. Inc. (Wilson) | Activity: Production and Manufacturing | Company Description Merck's Wilson facility produces patented prescription products and performs granulation and tableting operations. | Location Wilson |
| |
Company NIOX Group | Activity: Sales and Operations | Company Description NIOX is a diagnostics and management company focused on improving asthma diagnosis and management. | Location Morrisville |
| |
Company Novex Innovations LLC | Activity: Production and Manufacturing | Company Description Novex Innovations is a contract development and manufacturing organization (CDMO) supporting large, medium, small and startup life science companies in the development of their products, from concept through manufacturing and commercialization. | Location Winston-Salem |
| |
Company Novo Nordisk Pharmaceutical Industries LP (API facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Active Pharmaceutical Ingredient (API) facility produces the API for an oral diabetes treatment through fermentation, purification and recovery processes. | Location Clayton |
| |
Company Novo Nordisk Pharmaceutical Industries LP (Durham) | Activity: Production and Manufacturing | Company Description Novo Nordisk manufactures tablets for an oral GLP-1 treatment for type 2 diabetes. | Location Durham |
| |
Company Novo Nordisk Pharmaceutical Industries LP (IFP facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes. | Location Clayton |
| |
Company OmniAb Inc. (Durham) | Activity: Contract Research and Testing | Company Description OmniAb provides therapeutic antibody discovery technologies and antigen design. | Location Durham |
| |
Company Parion Sciences Inc. | Activity: Research and Development | Company Description Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory diseases. | Location Durham |
| |
Company ProKidney (Winston-Salem) | Activity: Production and Manufacturing | Company Description ProKidney manufactures cell therapy products that use a patient's own cells to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organs. | Location Winston-Salem |
| |
Company Reactive Biosciences Inc. | Activity: Research and Development | Company Description Reactive Biosciences uses a boron-based discovery platform to discover and develop new medicines. | Location Durham |
| |
Company RedHill Biopharma | Activity: Sales and Operations | Company Description RedHill Biopharma develops and commercializes orally-administered, small-molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer. Its Raleigh site is the company's U.S. commercial headquarters. | Location Tel-Aviv |
| |
Company Relion Inc. | Activity: Production and Manufacturing | Company Description Relion Manufacturing provides contract manufacturing and packaging services for the pharmaceutical, medical device and personal care industries. | Location Swannanoa |
| |
Company Ribometrix Inc. | Activity: Research and Development | Company Description Ribometrix is developing a new class of small-molecule therapeutics that directly target and modulate the function of RNA to treat human diseases. | Location Durham |
| |
Company Shattuck Labs Inc. | Activity: Research and Development | Company Description Shattuck Labs is a preclinical-stage immunotherapy company focused on utilizing its proprietary ARC (Agonist Redirected Checkpoint) technology to develop novel treatments for use in cancer, inflammation and orphan disease. | Location Durham |
| |
Company Sobi (Durham) | Activity: Research and Development | Company Description Sobi develops treatments for orphan diseases with a focus on inflammation and genetic diseases. | Location Durham |
| |
Company Sprout Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Sprout Pharmaceuticals has developed and markets a compound to treat hypoactive sexual desire disorder in women who have not gone through menopause. | Location Raleigh |
| |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary |
| |
Company TG Therapeutics Inc. | Activity: Research and Development | Company Description TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. | Location Morrisville |
| |
Company Tune Therapeutics | Activity: Research and Development | Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. | Location Durham |
| |
Company Verona Pharma Inc. | Activity: Research and Development | Company Description Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF). | Location Raleigh |
| |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham |